Liver X Receptor Agonists Exert Antitumor Effects against Hepatocellular Carcinoma via Inducing REPS2 Expression

The authors showed that T317 dose-dependently increased RalA binding protein 1-associated EPS domain containing 2 (REPS2) expression in normal hepatocytes and HCC cells.